Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Axsome Therapeutics (AXSM) Shares Outstanding (2021 - 2026)

Axsome Therapeutics' Shares Outstanding history spans 6 years, with the latest figure at $51.4 million for Q1 2026.

  • On a quarterly basis, Shares Outstanding rose 4.48% to $51.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $51.4 million, a 4.48% increase, with the full-year FY2025 number at $50.9 million, up 4.55% from a year prior.
  • Shares Outstanding hit $51.4 million in Q1 2026 for Axsome Therapeutics, up from $50.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AXSM hit a ceiling of $51.4 million in Q1 2026 and a floor of $4.8 million in Q2 2024.
  • Historically, Shares Outstanding has averaged $44.2 million across 5 years, with a median of $47.4 million in 2023.
  • Biggest five-year swings in Shares Outstanding: plummeted 89.77% in 2024 and later surged 942.13% in 2025.
  • Tracing AXSM's Shares Outstanding over 5 years: stood at $43.5 million in 2022, then rose by 8.86% to $47.4 million in 2023, then grew by 2.78% to $48.7 million in 2024, then grew by 4.55% to $50.9 million in 2025, then increased by 1.06% to $51.4 million in 2026.
  • Business Quant data shows Shares Outstanding for AXSM at $51.4 million in Q1 2026, $50.9 million in Q4 2025, and $50.3 million in Q3 2025.